169 related articles for article (PubMed ID: 2082907)
1. Dyslipoproteinaemia of liver disease.
Miller JP
Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):807-32. PubMed ID: 2082907
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
3. Alterations in lipoprotein composition associated with galactosamine-induced rat liver injury.
Cartwright CK; Ragland JB; Weidman SW; Sabesin SM
J Lipid Res; 1982 Jul; 23(5):667-79. PubMed ID: 7119568
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of lecithin:cholesterol acyltransferase on apolipoprotein distribution in familial lecithin:cholesterol acyltransferase deficiency.
Glomset JA; Mitchell CD; King WC; Applegate KA; Forte T; Norum KR; Gjone E
Ann N Y Acad Sci; 1980; 348():224-43. PubMed ID: 6930928
[TBL] [Abstract][Full Text] [Related]
5. Lecithin--cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice.
Agorastos J; Fox C; Harry DS; McIntyre N
Clin Sci Mol Med; 1978 Apr; 54(4):369-79. PubMed ID: 205385
[TBL] [Abstract][Full Text] [Related]
6. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease.
Day RC; Harry DS; Owen JS; Foo AY; McIntyre N
Clin Sci (Lond); 1979 Jan; 56(6):575-83. PubMed ID: 225095
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects.
Carlson LA; Holmquist L
Acta Med Scand; 1985; 218(2):197-205. PubMed ID: 4061123
[TBL] [Abstract][Full Text] [Related]
8. Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
Kwong LK; Ridinger DN; Bandhauer M; Ward JH; Samlowski WE; Iverius PH; Pritchard H; Wilson DE
J Clin Endocrinol Metab; 1997 May; 82(5):1572-81. PubMed ID: 9141552
[TBL] [Abstract][Full Text] [Related]
9. Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
Nagasaka H; Chiba H; Hui SP; Takikawa H; Miida T; Takayanagi M; Yorifuji T; Hasegawa M; Ota A; Hirano K; Kikuchi H; Tsukahara H; Kobayashi K
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):96-105. PubMed ID: 17592371
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
Watanabe M
Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
[TBL] [Abstract][Full Text] [Related]
11. LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.
Amar MJA; Freeman LA; Nishida T; Sampson ML; Pryor M; Vaisman BL; Neufeld EB; Karathanasis SK; Remaley AT
Pharmacol Res Perspect; 2020 Feb; 8(1):e00554. PubMed ID: 31893124
[TBL] [Abstract][Full Text] [Related]
12. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
Breier C; Lisch HJ; Braunsteiner H
Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
[TBL] [Abstract][Full Text] [Related]
13. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
O K; Frohlich J
J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
[TBL] [Abstract][Full Text] [Related]
14. Lecithin:cholesterol acyltransferase-induced transformation of HepG2 lipoproteins.
McCall MR; Nichols AV; Blanche PJ; Shore VG; Forte TM
J Lipid Res; 1989 Oct; 30(10):1579-89. PubMed ID: 2515238
[TBL] [Abstract][Full Text] [Related]
15. Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease.
Carlson LA; Holmquist L
Acta Med Scand; 1985; 218(2):189-96. PubMed ID: 4061122
[TBL] [Abstract][Full Text] [Related]
16. Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease.
Sabesin SM; Hawkins HL; Kuiken L; Ragland JB
Gastroenterology; 1977 Mar; 72(3):510-8. PubMed ID: 188710
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein metabolism in liver disease.
Sabesin SM; Bertram PD; Freeman MR
Adv Intern Med; 1980; 25():117-46. PubMed ID: 6987838
[TBL] [Abstract][Full Text] [Related]
18. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
[TBL] [Abstract][Full Text] [Related]
19. In vitro normalization of cholesteryl ester content and particle size of fish eye disease high density lipoproteins.
Holmquist L; Carlson LA
Acta Med Scand; 1987; 221(3):283-9. PubMed ID: 3591466
[TBL] [Abstract][Full Text] [Related]
20. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
